Loading clinical trials...
Loading clinical trials...
This study aims to analyze the expression of micro-RNA (miRNA) and long non-coding RNA (lncRNA) by next-generation sequencing in patients with high grade serous ovarian cancer (HGSOC) and benign gynecologic diseases. The candidate miRNA/lncRNA will be validated as biomarker for the detection and prognosis of HGSOC.
Age
18 - No limit years
Sex
FEMALE
Healthy Volunteers
No
Lei Li
Beijing, Beijing Municipality, China
Start Date
November 10, 2018
Primary Completion Date
November 23, 2019
Completion Date
November 23, 2019
Last Updated
November 14, 2018
160
ESTIMATED participants
Sequencing of miRNA/lncRNA
GENETIC
Lead Sponsor
Lei Li
NCT04550494
NCT05039801
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions